2023年

• 1: Matsuo R.
  Registry Studies of Stroke in Japan.
  J Atheroscler Thromb. 2023 Sep 1;30(9):1095-1103. doi: 10.5551/jat.RV22008. Epub 2023 Jul 19. PMID: 37468262; PMCID: PMC10499457.
• 2: Nonami A, Matsuo R, Funakoshi K, Nakayama T, Goto S, Iino T, Takaishi S, Mizuno S, Akashi K, Eto M.
  Prospective study of adoptive activated αβT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system.
  Cytotherapy. 2023 Jan;25(1):76-81. doi: 10.1016/j.jcyt.2022.09.007. Epub 2022 Oct 14. PMID: 36253253.
• 3: Matsumoto K, Nohara Y, Sakaguchi M, Takayama Y, Fukushige S, Soejima H, Nakashima N, Kamouchi M.
  Temporal Generalizability of Machine Learning Models for Predicting Postoperative Delirium Using Electronic Health Record Data: Model Development and Validation Study.
  JMIR Perioper Med. 2023 Oct 26;6:e50895. doi: 10.2196/50895. PMID: 37883164; PMCID: PMC10636625.
• 4: Shimizu W, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.
  Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study.
  Int J Cardiol. 2023 Nov 15;391:131290. doi: 10.1016/j.ijcard.2023.131290. Epub 2023 Aug 22. PMID: 37619876.
• 5: Nakamura K, Ueki K, Matsuo R, Kiyohara T, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
  Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study.
  PLoS One. 2023 Jun 29;18(6):e0287721. doi: 10.1371/journal.pone.0287721. PMID: 37384778; PMCID: PMC10309981.
• 6: Wakisaka K, Matsuo R, Matsumoto K, Nohara Y, Irie F, Wakisaka Y, Ago T, Nakashima N, Kamouchi M, Kitazono T.
  Non-linear association between body weight and functional outcome after acute ischemic stroke.
  Sci Rep. 2023 May 29;13(1):8697. doi: 10.1038/s41598-023-35894-y. PMID: 37248256; PMCID: PMC10226986.
• 7: Fujita T, Babazono A, Li Y, Jamal A, Kim SA.
  Hypnotics and injuries among older adults with Parkinson’s disease: a nested case-control design.
  BMC Geriatr. 2023 May 1;23(1):259. doi: 10.1186/s12877-023-03944-9. PMID: 37127561; PMCID: PMC10152606.
• 8: Ueki K, Matsuo R, Kuwashiro T, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
  Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study.
  Stroke. 2023 May;54(5):1268-1277. doi: 10.1161/STROKEAHA.122.040958. Epub 2023 Apr 6. PMID: 37021567.
• 9: Harano Y, Mitamura Y, Jiang P, Fujita T, Babazono A.
  Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase-4 inhibitors: A population-based cohort study using Japanese Latter-Stage Elderly Healthcare Database.
  J Diabetes Investig. 2023 Jun;14(6):756-766. doi: 10.1111/jdi.14004. Epub 2023 Mar 10. PMID: 36897510; PMCID: PMC10204174.
• 10: Kitazono T, Kamouchi M, Matsumaru Y, Shirai T, Takita A, Kuroda T, Kimura K.
  Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III.
  Cerebrovasc Dis. 2023;52(6):720-729. doi: 10.1159/000529149. Epub 2023 Apr 3. PMID: 37011599.
• 11: Ohya Y, Matsuo R, Sato N, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
  Modification of the effects of age on clinical outcomes through management of lifestyle-related factors in patients with acute ischemic stroke.
  J Neurol Sci. 2023 Mar 15;446:120589. doi: 10.1016/j.jns.2023.120589. Epub 2023 Feb 15. PMID: 36807976.
• 12: Irie F, Matsuo R, Nakamura K, Wakisaka Y, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
  Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry.
  Cerebrovasc Dis. 2023;52(4):409-416. doi: 10.1159/000526940. Epub 2023 Feb 8. PMID: 36754022.
• 13: Okita Y, Kitamura T, Komukai S, Zha L, Komatsu M, Narii N, Murata F, Megumi M, Gon Y, Kimura Y, Kiyohara K, Sobue T, Fukuda H.
  Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study.
  Int J Geriatr Psychiatry. 2023 Dec;38(12):e6029. doi: 10.1002/gps.6029. PMID: 38041399.
• 14: Tsuzuki S, Murata F, Maeda M, Asai Y, Koizumi R, Ohmagari N, Fukuda H.
  Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015-16 to 2020-21 seasons: from the VENUS study.
  J Antimicrob Chemother. 2023 Dec 1;78(12):2976-2982. doi: 10.1093/jac/dkad340. PMID: 37897719; PMCID: PMC10689917.
• 15: Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Maeda M, Murata F, Fukuda H.
  Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study.
  Open Forum Infect Dis. 2023 Oct 17;10(10):ofad475. doi: 10.1093/ofid/ofad475. PMID: 37869405; PMCID: PMC10588616.
• 16: Kamouchi M.
  Heart Failure　- Under-Recognized Link to Post-Stroke Functional Status.
  Circ J. 2023 Feb 24;87(3):409-411. doi: 10.1253/circj.CJ-22-0284. Epub 2022 May 28. PMID: 35644567.
• 17: Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Sato S, Kawazoe Y, Maeda M, Murata F, Fukuda H.
  Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged ≥65 years during the Delta variant predominance in Japan: The VENUS Study.
  J Epidemiol. 2023 Sep 23. doi: 10.2188/jea.JE20230106. Epub ahead of print. PMID: 37743530.
• 18: Fukuda H, Kanzaki H, Murata F, Maeda M, Ikeda M.
  Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer’s Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
  J Alzheimers Dis. 2023;95(4):1559-1572. doi: 10.3233/JAD-230471. PMID: 37718811; PMCID: PMC10578250.
• 19: Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
  Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study.
  Vaccine. 2023 Aug 23;41(37):5447-5453. doi: 10.1016/j.vaccine.2023.07.035. Epub 2023 Jul 22. PMID: 37487845.
• 20: Nakamura J, Nakatsuka K, Uchida K, Akisue T, Maeda M, Murata F, Fukuda H, Ono R.
  Analysis of post-extraction bleeding in patients taking antithrombotic therapy using data from the longevity improvement and fair evidence study.
  Gerodontology. 2023 Jul 19. doi: 10.1111/ger.12703. Epub ahead of print. PMID: 37469221.
• 21: Ishiguro C, Mimura W, Uemura Y, Maeda M, Murata F, Fukuda H.
  Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study.
  Open Forum Infect Dis. 2023 May 18;10(7):ofad274. doi: 10.1093/ofid/ofad274. PMID: 37404955; PMCID: PMC10316690.
• 22: Maeda M, Murata F, Fukuda H.
  Effect of COVID-19 vaccination on household transmission of SARS-CoV-2 in the Omicron era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
  Int J Infect Dis. 2023 Sep;134:200-206. doi: 10.1016/j.ijid.2023.06.017. Epub 2023 Jun 23. PMID: 37356650; PMCID: PMC10289267.
• 23: Onizuka H, Fukuda H.
  Associations between income changes and the risk of herpes zoster: LIFE study.
  Soc Sci Med. 2023 Jul;328:115981. doi: 10.1016/j.socscimed.2023.115981. Epub 2023 May 22. PMID: 37269744.
• 24: Fukuda H, Maeda M, Murata F.
  Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.
  Vaccine. 2023 May 26;41(23):3556-3563. doi: 10.1016/j.vaccine.2023.03.059. Epub 2023 Mar 29. PMID: 37037707; PMCID: PMC10050280.
• 25: Nakao T, Murayama K, Fukuda H, Eto N, Fujita K, Igata R, Ishikawa K, Isomura S, Kawaguchi T, Maeda M, Mitsuyasu H, Murata F, Nakamura T, Nishihara T, Ohashi A, Sato M, Yoshida Y, Kawasaki H, Ozone M, Yoshimura R, Tatebayashi H.
  Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in Japan.
  Brain Behav Immun Health. 2023 May;29:100615. doi: 10.1016/j.bbih.2023.100615. Epub 2023 Mar 24. PMID: 37008742; PMCID: PMC10036295.
• 26: Nakatsuka K, Ono R, Murata S, Akisue T, Fukuda H.
  Claimed-based frailty index in Japanese older adults: a cohort study using LIFE Study.
  J Epidemiol. 2023 Mar 25. doi: 10.2188/jea.JE20220310. Epub ahead of print. PMID: 36967119; PMCID: PMC10853043.
• 27: Kawabata J, Fukuda H.
  Effects of a financial incentive scheme for dementia care on medical and long-term care expenditures: A propensity score-matched analysis using LIFE study data.
  PLoS One. 2023 Mar 10;18(3):e0282965. doi: 10.1371/journal.pone.0282965. PMID: 36897916; PMCID: PMC10004481.
• 28: Narii N, Kitamura T, Komukai S, Zha L, Komatsu M, Murata F, Maeda M, Kiyohara K, Sobue T, Fukuda H.
  Association of pneumococcal vaccination with cardiovascular diseases in older adults: The vaccine effectiveness, networking, and universal safety (VENUS) study.
  Vaccine. 2023 Mar 24;41(13):2307-2313. doi: 10.1016/j.vaccine.2023.02.077. Epub 2023 Mar 2. PMID: 36870877.
• 29: Fukuda H, Murata F, Azuma S, Fujimoto M, Kudo S, Kobayashi Y, Saho K, Nakahara K, Ono R.
  Development of a data platform for monitoring personal health records in Japan: The Sustaining Health by Integrating Next-generation Ecosystems (SHINE) Study.
  PLoS One. 2023 Feb 14;18(2):e0281512. doi: 10.1371/journal.pone.0281512. PMID: 36787325; PMCID: PMC9928020.
• 30: Murata F, Maeda M, Fukuda H.
  Association between metabolic syndrome and participation in colorectal cancer screening in Japan: A retrospective cohort analysis using LIFE study data.
  Cancer Epidemiol. 2023 Apr;83:102335. doi: 10.1016/j.canep.2023.102335. Epub 2023 Feb 1. PMID: 36736056.
• 31: Adomi M, Maeda M, Murata F, Fukuda H.
  Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: Results from LIFE study.
  J Am Geriatr Soc. 2023 Jan;71(1):109-120. doi: 10.1111/jgs.18068. Epub 2022 Oct 2. PMID: 36184747.
• 32: Fukuda H, Ishiguro C, Ono R, Kiyohara K.
  The Longevity Improvement & Fair Evidence (LIFE) Study: Overview of the Study Design and Baseline Participant Profile.
  J Epidemiol. 2023 Aug 5;33(8):428-437. doi: 10.2188/jea.JE20210513. Epub 2022 Jun 24. PMID: 35753792; PMCID: PMC10319523.